Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Mesenchymal stem cells (MSCs) are the major source of osteoblasts. Long noncoding RNAs (lncRNAs) are abundantly expressed RNAs that lack protein-coding potential and play an extensive regulatory role in cellular biological activities. However, the regulatory network of lncRNAs in MSC osteogenesis needs further investigation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>QRT-PCR, western blot, immunofluorescence, and immunohistochemistry assays were used to determine the levels of relevant genes. The osteogenic differentiation capability was evaluated by using Alizarin Red S (ARS) staining, alkaline phosphatase activity assays, hematoxylin & eosin staining or micro-CT. RNA fluorescence in situ hybridization (FISH) and RNAscope were used to detect HHAS1 expression in cells and bone tissue. A microarray assay was performed to identify differentially expressed microRNAs. RNA immunoprecipitation and RNA pull-down were used to explore the interactions between related proteins and nucleic acids.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The level of lncRNA HHAS1 increased during bone marrow-derived MSC (BMSC) osteogenesis and was positively related to the levels of osteogenic genes and ARS intensity. HHAS1 was located in both the cytoplasm and the nucleus and was expressed in human bone tissue. HHAS1 facilitated BMSC osteogenic differentiation by downregulating miR-204-5p expression and enhancing the level of RUNX family transcription factor 2 (RUNX2). In addition, interferon regulatory factor 2 (IRF2) was increased during BMSC osteogenic differentiation and interacted with the promoter of HHAS1, which resulted in the transcriptional activation of HHAS1. Furthermore, IRF2 and HHAS1 helped improve bone defect repair in vivo.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our study identified a novel lncRNA, HHAS1, that facilitates BMSC osteogenic differentiation and proposed a role for the IRF2/HHAS1/miR-204-5p/RUNX2 axis in BMSC osteogenesis regulation. These findings help elucidate the regulatory network of BMSC osteogenesis and provide potential targets for clinical application.</p></section>

LncRNAs Transcriptome Analysis Revealed HIF1A-AS1 As a Mediator of Bone Remodeling Associated with the Micro Structured Titanium Surface

Integrated Analysis of Lncrna–mrna Networks Associated with an SLA Titanium Surface Reveals the Potential Role of HIF1A-AS1 in Bone Remodeling

Strontium-modified Titanium Substrate Promotes Osteogenic Differentiation of MSCs and Implant Osseointegration Via Upregulating CDH2

Modulating Autophagy by Strontium-Doped Micro/nano Rough Titanium Surface for Promotion of Osteogenesis and Inhibition of Osteoclastogenesis.

Gene Expression Profiling of Bone Marrow-Derived Stromal Cells Seeded Onto a Sandblasted, Large-Grit, Acid-Etched-treated Titanium Implant Surface: the Role of the Wnt Pathway

Microarray Analysis Reveals That Lncrna PWRN1-209 Promotes Human Bone Marrow Mesenchymal Stem Cell Osteogenic Differentiation on Microtopography Titanium Surface in Vitro.

Improved Osseointegration of Strontium-Modified Titanium Implants by Regulating Angiogenesis and Macrophage Polarization.

Effects of Strontium-Incorporated Micro/nano Rough Titanium Surfaces on Osseointegration Via Modulating Polarization of Macrophages.

ALX1-transcribed LncRNA AC132217.4 Promotes Osteogenesis and Bone Healing Via IGF-AKT Signaling in Mesenchymal Stem Cells

Genome-wide DNA-methylation profiles in human bone marrow mesenchymal stem cells on titanium surfaces.

Bioinformatics analysis and identification of circular RNAs promoting the osteogenic differentiation of human bone marrow mesenchymal stem cells on titanium treated by surface mechanical attrition

Antimicrobial peptide GL13K-Modified titanium in the epigenetic regulation of osteoclast differentiation via H3K27me3

mTORC2 regulates hierarchical micro/nano topography‐induced osteogenic differentiation via promoting cell adhesion and cytoskeletal polymerization

MiR-181d-5p Regulates Implant Surface Roughness-Induced Osteogenic Differentiation of Bone Marrow Stem Cells.

IRF2‐mediated upregulation of lncRNA HHAS1 facilitates the osteogenic differentiation of bone marrow‐derived mesenchymal stem cells by acting as a competing endogenous RNA

Microtopography “not” macrostructure affects the osteogenic differentiation of human mesenchymal stem cells through RHOA and LATS1

Correlation between LncRNA Profiles in the Blood Clot Formed on Nano-Scaled Implant Surfaces and Osseointegration

Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects

Long noncoding RNA AC092155 facilitates osteogenic differentiation of adipose-derived stem cells through the miR-143-3p/STMN1 axis

Identification of long non‐coding RNAs expressed during the�osteogenic differentiation of human bone marrow‐derived mesenchymal stem cells obtained from patients with ONFH

Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells